SlideShare une entreprise Scribd logo
1  sur  20
INITIAL SUCCESS RATE ANDINITIAL SUCCESS RATE AND
PREDICTORS OF PROCEDURALPREDICTORS OF PROCEDURAL
FAILURE IN PERCUTANEOUSFAILURE IN PERCUTANEOUS
CORONARY INTERVENTION ONCORONARY INTERVENTION ON
CHRONIC TOTAL OCCULUSION(CHRONIC TOTAL OCCULUSION( CTOCTO))
LESIONSLESIONS
Shahriyari Afshar M.Shahriyari Afshar M.
Arefi HArefi H..
Nadi S.Nadi S.
Shariati Hospital, Cardiovascular DepartmentShariati Hospital, Cardiovascular Department
Tehran University of Medical Sciences,2006Tehran University of Medical Sciences,2006
ObjectiveObjective
 The aim of this study wasThe aim of this study was
investigation ofinvestigation of initial success rateinitial success rate
and theand the early clinical outcomeearly clinical outcome andand
predicators of procedural failurepredicators of procedural failure inin
percutaneous coronary interventionpercutaneous coronary intervention
on Chronic Total Occlusion withon Chronic Total Occlusion with
conventional angioplasty wires atconventional angioplasty wires at
Shariati hospital, April 2005-2006.Shariati hospital, April 2005-2006.
MethodsMethods
 Forty six patients,Forty six patients, 37 men37 men andand
9 women9 women, 28-81 years old, with, 28-81 years old, with ChronicChronic
Total OcclusionTotal Occlusion enrolled in this study.enrolled in this study.
 Forty eightForty eight Chronic Total OcclusionsChronic Total Occlusions werewere
confirmed in 46 patients with angiography.confirmed in 46 patients with angiography.
 The end points wereThe end points were technical andtechnical and
procedural successprocedural success, and, and in hospital majorin hospital major
adverse cardiac eventsadverse cardiac events occurrence andoccurrence and
predictors of procedural failurepredictors of procedural failure..
ResultsResults
 Relative frequency of risk factorsRelative frequency of risk factors
 Diabetes mellitusDiabetes mellitus 1313 %%
 HypertensionHypertension 2828 %%
 DyslipidemiaDyslipidemia 4747 %%
 Cigarette smokingCigarette smoking 4545 %%
 Positive family historyPositive family history 6.56.5 %%
 No risk factorNo risk factor 1313 %%
ResultsResults Cont,Cont,
 84 %84 % had history ofhad history of myocardialmyocardial
infarctioninfarction
 Mean durationMean duration of MI to procedure wasof MI to procedure was
73 days73 days..
ResultsResults Cont,Cont,
 Location of CTOLocation of CTO
 RCARCA 5050 %%
 LADLAD 31.131.1 %%
 LCXLCX 18.818.8 %%
 Portion of CTOPortion of CTO
 Proximal partProximal part 47.947.9 %%
 Mid part of vesselsMid part of vessels 52.152.1 %%
ResultsResults Cont,Cont,
 Length of OcclusionLength of Occlusion
 < 1< 1 cmcm 6.76.7 %%
 1 ~ 31 ~ 3 cmcm 5656 %%
 > 3> 3 cmcm 33.333.3 %%
 Collateral flowCollateral flow
 SeenSeen 89.689.6 %%
 Not seenNot seen 10.410.4 %%
 TIMI flowTIMI flow
 SeenSeen 56.256.2 %%
 Not seenNot seen 43.843.8 %%
ResultsResults Cont,Cont,
 Taper StumpTaper Stump
 SeenSeen 79.279.2 %%
 Not seenNot seen 20.820.8 %%
 Coronary CalcificationCoronary Calcification
 SeenSeen 10.410.4 %%
 Not seenNot seen 89.689.6 %%
ResultsResults Cont,Cont,
 Other lesion in Culprit VesselOther lesion in Culprit Vessel
 SeenSeen 3535 %%
 Not seenNot seen 6565 %%
 Lesion in other VesselsLesion in other Vessels
 SeenSeen 52.252.2 %%
 Not seenNot seen 47.847.8 %%
ResultsResults Cont,Cont,
 The most common type of guide wire wasThe most common type of guide wire was
BMW, 0.014”BMW, 0.014”
Type of GWType of GW FrequencyFrequency PercentagePercentage
BMWBMW 3434 70.870.8
BHWBHW 66 12.512.5
CougarCougar 66 12.512.5
AsahiAsahi
FIELDERFIELDER
11 2.12.1
choISEchoISE
FloppyFloppy
11 2.12.1
Guide wire passage:
Successful 81.3 %
Unsuccessful 8.7 %
Results Cont,
ResultsResults Cont,Cont,
 Predilation pressurePredilation pressure
 > 10 atm> 10 atm 6262 %%
 < 10 atm< 10 atm 3838 %%
 In one case onlyIn one case only balloonballoon was notwas not
passedpassed
ResultsResults Cont,Cont,
 Type of StentType of Stent
 Bare Metal Stent (BMS)Bare Metal Stent (BMS) 8080 %%
 Drug Eluting Stent (DES)Drug Eluting Stent (DES) 2020 %%
 In all casesIn all cases TIMI 3TIMI 3 andand residualresidual
stenosis < 30 %stenosis < 30 % were achievedwere achieved
 No Major Adverse Cardiac EventsNo Major Adverse Cardiac Events
(MACE)(MACE) in hospital was notedin hospital was noted
ResultsResults Cont,Cont,
 TechnicalTechnical andand proceduralprocedural
successsuccess was obtained inwas obtained in 79.2 %79.2 %
ofof Chronic Total OcclusionsChronic Total Occlusions..
ResultsResults Cont,Cont,
 Univariate and multivariate analysis ofUnivariate and multivariate analysis of
predictors of PCI failurepredictors of PCI failure
 AgeAge
 SexSex
 History of InfarctionHistory of Infarction
 Location of InfarctionLocation of Infarction
 Duration of InfarctionDuration of Infarction
 SmokingSmoking was a significant predictors ofwas a significant predictors of
Percutaneous Coronary Intervention failure.Percutaneous Coronary Intervention failure.
Smoke Odds ratio = 0.16, P value = 0.034Smoke Odds ratio = 0.16, P value = 0.034
 DiabetesDiabetes
 DyslipidemiaDyslipidemia
 HypertensionHypertension
 Family History of IHDFamily History of IHD
 SmokingSmoking
PredictorsPredictors P ValueP Value Odd Ratio (95% CI)Odd Ratio (95% CI)
AgeAge 0.080.08 0.940.94 (0.89 - 1.00)(0.89 - 1.00)
SexSex 0.440.44 2.42.4 (0.26 - 21.84)(0.26 - 21.84)
MI HistoryMI History 0.750.75 1.331.33 (0.22 - 0.89)(0.22 - 0.89)
MI LocationMI Location 0.780.78 0.920.92 (0.53 - 1.61)(0.53 - 1.61)
MI DurationMI Duration 0.210.21 0.990.99 (0.98 - 1.00)(0.98 - 1.00)
DMDM 0.790.79 1.361.36 (0.14 - 13.20)(0.14 - 13.20)
DLPDLP 0.770.77 0.810.81 (0.20 - 3.27)(0.20 - 3.27)
HTNHTN 0.160.16 0.360.36 (0.08 - 1.50)(0.08 - 1.50)
CigaretteCigarette
SmokingSmoking
0.0340.034 0.160.16 (0.03 - 0.87)(0.03 - 0.87)
FHFH 0.160.16 0.220.22 (0.03 - 1.82)(0.03 - 1.82)
ResultsResults Cont,Cont,
ConclusionsConclusions
 UsingUsing conventional angioplasty wiresconventional angioplasty wires
inin CTOCTO
 High percentage of SuccessfulHigh percentage of Successful
Percutaneous Coronary InterventionPercutaneous Coronary Intervention
was achievedwas achieved
 Low incidence of complicationsLow incidence of complications waswas
seenseen
 SmokingSmoking was a significant predictorwas a significant predictor
of procedural failureof procedural failure
 Smoking was a significant predictor
of procedural failure

Contenu connexe

Tendances

17:05 Goicolea - Changes after CTO Recanilization
17:05 Goicolea - Changes after CTO Recanilization17:05 Goicolea - Changes after CTO Recanilization
17:05 Goicolea - Changes after CTO RecanilizationEuro CTO Club
 
16:55 Antoniucci - Stenting in CTO
16:55 Antoniucci - Stenting in CTO16:55 Antoniucci - Stenting in CTO
16:55 Antoniucci - Stenting in CTOEuro CTO Club
 
14:35 Yamane - Update Japanese Multicenter Registry
14:35 Yamane -  Update Japanese Multicenter Registry14:35 Yamane -  Update Japanese Multicenter Registry
14:35 Yamane - Update Japanese Multicenter RegistryEuro CTO Club
 
Endoscopic Cardiac Surgery in Taiwan
Endoscopic Cardiac Surgery in TaiwanEndoscopic Cardiac Surgery in Taiwan
Endoscopic Cardiac Surgery in TaiwanRobert Chen
 
Left atrial appendage occlusion during cardiac surgery to prevent stroke laao...
Left atrial appendage occlusion during cardiac surgery to prevent stroke laao...Left atrial appendage occlusion during cardiac surgery to prevent stroke laao...
Left atrial appendage occlusion during cardiac surgery to prevent stroke laao...FIRAS ALJANADI
 
PROTECT-AF trial - Summary & Results
PROTECT-AF trial - Summary & ResultsPROTECT-AF trial - Summary & Results
PROTECT-AF trial - Summary & Resultstheheart.org
 
Summary of landmark CTO clinical trials and highlights from registries
Summary of landmark CTO clinical trials and highlights from registries Summary of landmark CTO clinical trials and highlights from registries
Summary of landmark CTO clinical trials and highlights from registries AhmedElBorae1
 
AUA abstract 2014
AUA abstract 2014AUA abstract 2014
AUA abstract 2014Wenjeng Li
 
’iFR uncovers profound but mostly reversible ischemia in CTOs and helps to op...
’iFR uncovers profound but mostly reversible ischemia in CTOs and helps to op...’iFR uncovers profound but mostly reversible ischemia in CTOs and helps to op...
’iFR uncovers profound but mostly reversible ischemia in CTOs and helps to op...Euro CTO Club
 
CTO recanalization: when, why, how?
CTO recanalization: when, why, how?CTO recanalization: when, why, how?
CTO recanalization: when, why, how?Euro CTO Club
 

Tendances (20)

17:05 Goicolea - Changes after CTO Recanilization
17:05 Goicolea - Changes after CTO Recanilization17:05 Goicolea - Changes after CTO Recanilization
17:05 Goicolea - Changes after CTO Recanilization
 
Louvard Y - AIMRADIAL 2014 - Sheathless
Louvard Y - AIMRADIAL 2014 - SheathlessLouvard Y - AIMRADIAL 2014 - Sheathless
Louvard Y - AIMRADIAL 2014 - Sheathless
 
16:55 Antoniucci - Stenting in CTO
16:55 Antoniucci - Stenting in CTO16:55 Antoniucci - Stenting in CTO
16:55 Antoniucci - Stenting in CTO
 
14:35 Yamane - Update Japanese Multicenter Registry
14:35 Yamane -  Update Japanese Multicenter Registry14:35 Yamane -  Update Japanese Multicenter Registry
14:35 Yamane - Update Japanese Multicenter Registry
 
Gilchrist IC - AIMRADIAL 2014 Technical - Right heart
Gilchrist IC - AIMRADIAL 2014 Technical - Right heartGilchrist IC - AIMRADIAL 2014 Technical - Right heart
Gilchrist IC - AIMRADIAL 2014 Technical - Right heart
 
Endoscopic Cardiac Surgery in Taiwan
Endoscopic Cardiac Surgery in TaiwanEndoscopic Cardiac Surgery in Taiwan
Endoscopic Cardiac Surgery in Taiwan
 
Left atrial appendage occlusion during cardiac surgery to prevent stroke laao...
Left atrial appendage occlusion during cardiac surgery to prevent stroke laao...Left atrial appendage occlusion during cardiac surgery to prevent stroke laao...
Left atrial appendage occlusion during cardiac surgery to prevent stroke laao...
 
Yeh RW - Femoral vs radial: evidence - 201507
Yeh RW - Femoral vs radial: evidence - 201507Yeh RW - Femoral vs radial: evidence - 201507
Yeh RW - Femoral vs radial: evidence - 201507
 
PROTECT-AF trial - Summary & Results
PROTECT-AF trial - Summary & ResultsPROTECT-AF trial - Summary & Results
PROTECT-AF trial - Summary & Results
 
Sheets JD 2016 Transradial robotic PCI
Sheets JD 2016 Transradial robotic PCISheets JD 2016 Transradial robotic PCI
Sheets JD 2016 Transradial robotic PCI
 
Chevalier B
Chevalier BChevalier B
Chevalier B
 
Aminian A 2016 Glidesheath Slender for transradial
Aminian A 2016 Glidesheath Slender for transradialAminian A 2016 Glidesheath Slender for transradial
Aminian A 2016 Glidesheath Slender for transradial
 
Tizon-Marcos et al
Tizon-Marcos et alTizon-Marcos et al
Tizon-Marcos et al
 
Summary of landmark CTO clinical trials and highlights from registries
Summary of landmark CTO clinical trials and highlights from registries Summary of landmark CTO clinical trials and highlights from registries
Summary of landmark CTO clinical trials and highlights from registries
 
AUA abstract 2014
AUA abstract 2014AUA abstract 2014
AUA abstract 2014
 
’iFR uncovers profound but mostly reversible ischemia in CTOs and helps to op...
’iFR uncovers profound but mostly reversible ischemia in CTOs and helps to op...’iFR uncovers profound but mostly reversible ischemia in CTOs and helps to op...
’iFR uncovers profound but mostly reversible ischemia in CTOs and helps to op...
 
Bernat I 201111
Bernat I 201111Bernat I 201111
Bernat I 201111
 
Ruzsa Z - AIMRADIAL 2015 - Radial access for subclavian intervention
Ruzsa Z - AIMRADIAL 2015 - Radial access for subclavian interventionRuzsa Z - AIMRADIAL 2015 - Radial access for subclavian intervention
Ruzsa Z - AIMRADIAL 2015 - Radial access for subclavian intervention
 
CTO recanalization: when, why, how?
CTO recanalization: when, why, how?CTO recanalization: when, why, how?
CTO recanalization: when, why, how?
 
Tizon-Marcos et al
Tizon-Marcos et alTizon-Marcos et al
Tizon-Marcos et al
 

En vedette

Meet patel(ppt) cs[1]
Meet patel(ppt) cs[1]Meet patel(ppt) cs[1]
Meet patel(ppt) cs[1]PatelHarsh28
 
Bioinformatics lecture xxiii
Bioinformatics lecture xxiiiBioinformatics lecture xxiii
Bioinformatics lecture xxiiiMuhammad Younis
 
Mathematics of investment and credit, 5th edition
Mathematics of investment and credit, 5th editionMathematics of investment and credit, 5th edition
Mathematics of investment and credit, 5th editionAmer Rb
 
SPOT Egitim Danismanlik - Paylasilan Liderlik - PL024 Ekim 15
SPOT Egitim Danismanlik - Paylasilan Liderlik - PL024 Ekim 15SPOT Egitim Danismanlik - Paylasilan Liderlik - PL024 Ekim 15
SPOT Egitim Danismanlik - Paylasilan Liderlik - PL024 Ekim 15Ufuk Kaya
 
Triangle Apartment Association Bus Tour Booklet_2015
Triangle Apartment Association Bus Tour Booklet_2015Triangle Apartment Association Bus Tour Booklet_2015
Triangle Apartment Association Bus Tour Booklet_2015Jeff Glenn
 
Embedded system by abhishek mahajan
Embedded system by abhishek mahajanEmbedded system by abhishek mahajan
Embedded system by abhishek mahajanabhimaha09
 

En vedette (14)

Genre of magazine.
Genre of magazine.Genre of magazine.
Genre of magazine.
 
Ppt intan
Ppt intanPpt intan
Ppt intan
 
VinayKumar_Sirikonda
VinayKumar_SirikondaVinayKumar_Sirikonda
VinayKumar_Sirikonda
 
Y.shopper.v4
Y.shopper.v4Y.shopper.v4
Y.shopper.v4
 
iOS_Presentation
iOS_PresentationiOS_Presentation
iOS_Presentation
 
Star theory (2)
Star theory (2)Star theory (2)
Star theory (2)
 
Meet patel(ppt) cs[1]
Meet patel(ppt) cs[1]Meet patel(ppt) cs[1]
Meet patel(ppt) cs[1]
 
Bioinformatics lecture xxiii
Bioinformatics lecture xxiiiBioinformatics lecture xxiii
Bioinformatics lecture xxiii
 
Mathematics of investment and credit, 5th edition
Mathematics of investment and credit, 5th editionMathematics of investment and credit, 5th edition
Mathematics of investment and credit, 5th edition
 
RyanResumeUpdated (2015
RyanResumeUpdated (2015RyanResumeUpdated (2015
RyanResumeUpdated (2015
 
SPOT Egitim Danismanlik - Paylasilan Liderlik - PL024 Ekim 15
SPOT Egitim Danismanlik - Paylasilan Liderlik - PL024 Ekim 15SPOT Egitim Danismanlik - Paylasilan Liderlik - PL024 Ekim 15
SPOT Egitim Danismanlik - Paylasilan Liderlik - PL024 Ekim 15
 
Triangle Apartment Association Bus Tour Booklet_2015
Triangle Apartment Association Bus Tour Booklet_2015Triangle Apartment Association Bus Tour Booklet_2015
Triangle Apartment Association Bus Tour Booklet_2015
 
Embedded system by abhishek mahajan
Embedded system by abhishek mahajanEmbedded system by abhishek mahajan
Embedded system by abhishek mahajan
 
Verbs compound blog
Verbs compound blogVerbs compound blog
Verbs compound blog
 

Similaire à CTO Intervention Predictors, Dr Shahriyari

Chronic Total Occlusions: The Road Less Traveled
Chronic Total Occlusions: The Road Less TraveledChronic Total Occlusions: The Road Less Traveled
Chronic Total Occlusions: The Road Less TraveledAllina Health
 
2006 terni, workshop interattivo. la terapia ablativa percutanea della fibril...
2006 terni, workshop interattivo. la terapia ablativa percutanea della fibril...2006 terni, workshop interattivo. la terapia ablativa percutanea della fibril...
2006 terni, workshop interattivo. la terapia ablativa percutanea della fibril...Centro Diagnostico Nardi
 
A technical modification of carotid endarterectomy experience with 400 pati...
A technical modification of carotid endarterectomy   experience with 400 pati...A technical modification of carotid endarterectomy   experience with 400 pati...
A technical modification of carotid endarterectomy experience with 400 pati...uvcd
 
ga30102020son.pptx
ga30102020son.pptxga30102020son.pptx
ga30102020son.pptxgursel2
 
Pci or throm or pi in stemi best strategy(apicon 09022019)-final
Pci or throm or pi in stemi best strategy(apicon 09022019)-finalPci or throm or pi in stemi best strategy(apicon 09022019)-final
Pci or throm or pi in stemi best strategy(apicon 09022019)-finalDr.Vinod Sharma
 
Foro Epic _ Oclusión Crónica Total (CTO): Intervención Coronaria Percutánea (...
Foro Epic _ Oclusión Crónica Total (CTO): Intervención Coronaria Percutánea (...Foro Epic _ Oclusión Crónica Total (CTO): Intervención Coronaria Percutánea (...
Foro Epic _ Oclusión Crónica Total (CTO): Intervención Coronaria Percutánea (...Foro Epic
 
2007 pizzo calabro, convegno regionale anmco. quale approccio ablativo nella ...
2007 pizzo calabro, convegno regionale anmco. quale approccio ablativo nella ...2007 pizzo calabro, convegno regionale anmco. quale approccio ablativo nella ...
2007 pizzo calabro, convegno regionale anmco. quale approccio ablativo nella ...Centro Diagnostico Nardi
 
2009 bologna, af & chf congress, ablazione della fibrillazione atriale. obiet...
2009 bologna, af & chf congress, ablazione della fibrillazione atriale. obiet...2009 bologna, af & chf congress, ablazione della fibrillazione atriale. obiet...
2009 bologna, af & chf congress, ablazione della fibrillazione atriale. obiet...Centro Diagnostico Nardi
 
2009 ferrara, congresso regionale, i tools da raggiungere nell'ablazione dell...
2009 ferrara, congresso regionale, i tools da raggiungere nell'ablazione dell...2009 ferrara, congresso regionale, i tools da raggiungere nell'ablazione dell...
2009 ferrara, congresso regionale, i tools da raggiungere nell'ablazione dell...Centro Diagnostico Nardi
 
Samir rafla real life outcome of atrial fibrillation ablation-cardio alex 2014
Samir rafla  real life outcome of atrial fibrillation ablation-cardio alex 2014Samir rafla  real life outcome of atrial fibrillation ablation-cardio alex 2014
Samir rafla real life outcome of atrial fibrillation ablation-cardio alex 2014Alexandria University, Egypt
 
TORO. Registro Español de Oclusión Crónica total secundaria a restenosis oclu...
TORO. Registro Español de Oclusión Crónica total secundaria a restenosis oclu...TORO. Registro Español de Oclusión Crónica total secundaria a restenosis oclu...
TORO. Registro Español de Oclusión Crónica total secundaria a restenosis oclu...Sociedad Española de Cardiología
 
Antegrade approach to coronary chronic total occlusion
Antegrade approach to coronary chronic total occlusionAntegrade approach to coronary chronic total occlusion
Antegrade approach to coronary chronic total occlusionRamachandra Barik
 
Weighted angiographic scoring model (w cto score)
Weighted angiographic scoring model (w cto score)Weighted angiographic scoring model (w cto score)
Weighted angiographic scoring model (w cto score)Ramachandra Barik
 
Percutanous PVL closure
Percutanous PVL closurePercutanous PVL closure
Percutanous PVL closureAhmedElBorae1
 
Kambis Mashayekhi: Haemodynamic support during CTO PCI
Kambis Mashayekhi: Haemodynamic support during CTO PCI Kambis Mashayekhi: Haemodynamic support during CTO PCI
Kambis Mashayekhi: Haemodynamic support during CTO PCI Euro CTO Club
 

Similaire à CTO Intervention Predictors, Dr Shahriyari (20)

Pancholy SB 2014
Pancholy SB 2014Pancholy SB 2014
Pancholy SB 2014
 
Cheema A 201111
Cheema A 201111Cheema A 201111
Cheema A 201111
 
Chronic Total Occlusions: The Road Less Traveled
Chronic Total Occlusions: The Road Less TraveledChronic Total Occlusions: The Road Less Traveled
Chronic Total Occlusions: The Road Less Traveled
 
2006 terni, workshop interattivo. la terapia ablativa percutanea della fibril...
2006 terni, workshop interattivo. la terapia ablativa percutanea della fibril...2006 terni, workshop interattivo. la terapia ablativa percutanea della fibril...
2006 terni, workshop interattivo. la terapia ablativa percutanea della fibril...
 
A technical modification of carotid endarterectomy experience with 400 pati...
A technical modification of carotid endarterectomy   experience with 400 pati...A technical modification of carotid endarterectomy   experience with 400 pati...
A technical modification of carotid endarterectomy experience with 400 pati...
 
ga30102020son.pptx
ga30102020son.pptxga30102020son.pptx
ga30102020son.pptx
 
Pci or throm or pi in stemi best strategy(apicon 09022019)-final
Pci or throm or pi in stemi best strategy(apicon 09022019)-finalPci or throm or pi in stemi best strategy(apicon 09022019)-final
Pci or throm or pi in stemi best strategy(apicon 09022019)-final
 
Foro Epic _ Oclusión Crónica Total (CTO): Intervención Coronaria Percutánea (...
Foro Epic _ Oclusión Crónica Total (CTO): Intervención Coronaria Percutánea (...Foro Epic _ Oclusión Crónica Total (CTO): Intervención Coronaria Percutánea (...
Foro Epic _ Oclusión Crónica Total (CTO): Intervención Coronaria Percutánea (...
 
2007 pizzo calabro, convegno regionale anmco. quale approccio ablativo nella ...
2007 pizzo calabro, convegno regionale anmco. quale approccio ablativo nella ...2007 pizzo calabro, convegno regionale anmco. quale approccio ablativo nella ...
2007 pizzo calabro, convegno regionale anmco. quale approccio ablativo nella ...
 
2009 bologna, af & chf congress, ablazione della fibrillazione atriale. obiet...
2009 bologna, af & chf congress, ablazione della fibrillazione atriale. obiet...2009 bologna, af & chf congress, ablazione della fibrillazione atriale. obiet...
2009 bologna, af & chf congress, ablazione della fibrillazione atriale. obiet...
 
2009 ferrara, congresso regionale, i tools da raggiungere nell'ablazione dell...
2009 ferrara, congresso regionale, i tools da raggiungere nell'ablazione dell...2009 ferrara, congresso regionale, i tools da raggiungere nell'ablazione dell...
2009 ferrara, congresso regionale, i tools da raggiungere nell'ablazione dell...
 
Samir rafla real life outcome of atrial fibrillation ablation-cardio alex 2014
Samir rafla  real life outcome of atrial fibrillation ablation-cardio alex 2014Samir rafla  real life outcome of atrial fibrillation ablation-cardio alex 2014
Samir rafla real life outcome of atrial fibrillation ablation-cardio alex 2014
 
Dharma S - AIMRADIAL 2014 - Nitroglycerin and radial artery occlusion
 Dharma S - AIMRADIAL 2014 - Nitroglycerin and radial artery occlusion Dharma S - AIMRADIAL 2014 - Nitroglycerin and radial artery occlusion
Dharma S - AIMRADIAL 2014 - Nitroglycerin and radial artery occlusion
 
Jose r lopez minguez novedades cierre laa
Jose r lopez minguez novedades cierre laaJose r lopez minguez novedades cierre laa
Jose r lopez minguez novedades cierre laa
 
THE GISE TAVI POSITION PAPER
THE GISE TAVI POSITION PAPERTHE GISE TAVI POSITION PAPER
THE GISE TAVI POSITION PAPER
 
TORO. Registro Español de Oclusión Crónica total secundaria a restenosis oclu...
TORO. Registro Español de Oclusión Crónica total secundaria a restenosis oclu...TORO. Registro Español de Oclusión Crónica total secundaria a restenosis oclu...
TORO. Registro Español de Oclusión Crónica total secundaria a restenosis oclu...
 
Antegrade approach to coronary chronic total occlusion
Antegrade approach to coronary chronic total occlusionAntegrade approach to coronary chronic total occlusion
Antegrade approach to coronary chronic total occlusion
 
Weighted angiographic scoring model (w cto score)
Weighted angiographic scoring model (w cto score)Weighted angiographic scoring model (w cto score)
Weighted angiographic scoring model (w cto score)
 
Percutanous PVL closure
Percutanous PVL closurePercutanous PVL closure
Percutanous PVL closure
 
Kambis Mashayekhi: Haemodynamic support during CTO PCI
Kambis Mashayekhi: Haemodynamic support during CTO PCI Kambis Mashayekhi: Haemodynamic support during CTO PCI
Kambis Mashayekhi: Haemodynamic support during CTO PCI
 

CTO Intervention Predictors, Dr Shahriyari

  • 1. INITIAL SUCCESS RATE ANDINITIAL SUCCESS RATE AND PREDICTORS OF PROCEDURALPREDICTORS OF PROCEDURAL FAILURE IN PERCUTANEOUSFAILURE IN PERCUTANEOUS CORONARY INTERVENTION ONCORONARY INTERVENTION ON CHRONIC TOTAL OCCULUSION(CHRONIC TOTAL OCCULUSION( CTOCTO)) LESIONSLESIONS Shahriyari Afshar M.Shahriyari Afshar M. Arefi HArefi H.. Nadi S.Nadi S. Shariati Hospital, Cardiovascular DepartmentShariati Hospital, Cardiovascular Department Tehran University of Medical Sciences,2006Tehran University of Medical Sciences,2006
  • 2. ObjectiveObjective  The aim of this study wasThe aim of this study was investigation ofinvestigation of initial success rateinitial success rate and theand the early clinical outcomeearly clinical outcome andand predicators of procedural failurepredicators of procedural failure inin percutaneous coronary interventionpercutaneous coronary intervention on Chronic Total Occlusion withon Chronic Total Occlusion with conventional angioplasty wires atconventional angioplasty wires at Shariati hospital, April 2005-2006.Shariati hospital, April 2005-2006.
  • 3. MethodsMethods  Forty six patients,Forty six patients, 37 men37 men andand 9 women9 women, 28-81 years old, with, 28-81 years old, with ChronicChronic Total OcclusionTotal Occlusion enrolled in this study.enrolled in this study.  Forty eightForty eight Chronic Total OcclusionsChronic Total Occlusions werewere confirmed in 46 patients with angiography.confirmed in 46 patients with angiography.  The end points wereThe end points were technical andtechnical and procedural successprocedural success, and, and in hospital majorin hospital major adverse cardiac eventsadverse cardiac events occurrence andoccurrence and predictors of procedural failurepredictors of procedural failure..
  • 4.
  • 5.
  • 6. ResultsResults  Relative frequency of risk factorsRelative frequency of risk factors  Diabetes mellitusDiabetes mellitus 1313 %%  HypertensionHypertension 2828 %%  DyslipidemiaDyslipidemia 4747 %%  Cigarette smokingCigarette smoking 4545 %%  Positive family historyPositive family history 6.56.5 %%  No risk factorNo risk factor 1313 %%
  • 7. ResultsResults Cont,Cont,  84 %84 % had history ofhad history of myocardialmyocardial infarctioninfarction  Mean durationMean duration of MI to procedure wasof MI to procedure was 73 days73 days..
  • 8. ResultsResults Cont,Cont,  Location of CTOLocation of CTO  RCARCA 5050 %%  LADLAD 31.131.1 %%  LCXLCX 18.818.8 %%  Portion of CTOPortion of CTO  Proximal partProximal part 47.947.9 %%  Mid part of vesselsMid part of vessels 52.152.1 %%
  • 9. ResultsResults Cont,Cont,  Length of OcclusionLength of Occlusion  < 1< 1 cmcm 6.76.7 %%  1 ~ 31 ~ 3 cmcm 5656 %%  > 3> 3 cmcm 33.333.3 %%  Collateral flowCollateral flow  SeenSeen 89.689.6 %%  Not seenNot seen 10.410.4 %%  TIMI flowTIMI flow  SeenSeen 56.256.2 %%  Not seenNot seen 43.843.8 %%
  • 10. ResultsResults Cont,Cont,  Taper StumpTaper Stump  SeenSeen 79.279.2 %%  Not seenNot seen 20.820.8 %%  Coronary CalcificationCoronary Calcification  SeenSeen 10.410.4 %%  Not seenNot seen 89.689.6 %%
  • 11. ResultsResults Cont,Cont,  Other lesion in Culprit VesselOther lesion in Culprit Vessel  SeenSeen 3535 %%  Not seenNot seen 6565 %%  Lesion in other VesselsLesion in other Vessels  SeenSeen 52.252.2 %%  Not seenNot seen 47.847.8 %%
  • 12. ResultsResults Cont,Cont,  The most common type of guide wire wasThe most common type of guide wire was BMW, 0.014”BMW, 0.014” Type of GWType of GW FrequencyFrequency PercentagePercentage BMWBMW 3434 70.870.8 BHWBHW 66 12.512.5 CougarCougar 66 12.512.5 AsahiAsahi FIELDERFIELDER 11 2.12.1 choISEchoISE FloppyFloppy 11 2.12.1
  • 13. Guide wire passage: Successful 81.3 % Unsuccessful 8.7 % Results Cont,
  • 14. ResultsResults Cont,Cont,  Predilation pressurePredilation pressure  > 10 atm> 10 atm 6262 %%  < 10 atm< 10 atm 3838 %%  In one case onlyIn one case only balloonballoon was notwas not passedpassed
  • 15. ResultsResults Cont,Cont,  Type of StentType of Stent  Bare Metal Stent (BMS)Bare Metal Stent (BMS) 8080 %%  Drug Eluting Stent (DES)Drug Eluting Stent (DES) 2020 %%  In all casesIn all cases TIMI 3TIMI 3 andand residualresidual stenosis < 30 %stenosis < 30 % were achievedwere achieved  No Major Adverse Cardiac EventsNo Major Adverse Cardiac Events (MACE)(MACE) in hospital was notedin hospital was noted
  • 16. ResultsResults Cont,Cont,  TechnicalTechnical andand proceduralprocedural successsuccess was obtained inwas obtained in 79.2 %79.2 % ofof Chronic Total OcclusionsChronic Total Occlusions..
  • 17. ResultsResults Cont,Cont,  Univariate and multivariate analysis ofUnivariate and multivariate analysis of predictors of PCI failurepredictors of PCI failure  AgeAge  SexSex  History of InfarctionHistory of Infarction  Location of InfarctionLocation of Infarction  Duration of InfarctionDuration of Infarction  SmokingSmoking was a significant predictors ofwas a significant predictors of Percutaneous Coronary Intervention failure.Percutaneous Coronary Intervention failure. Smoke Odds ratio = 0.16, P value = 0.034Smoke Odds ratio = 0.16, P value = 0.034  DiabetesDiabetes  DyslipidemiaDyslipidemia  HypertensionHypertension  Family History of IHDFamily History of IHD  SmokingSmoking
  • 18. PredictorsPredictors P ValueP Value Odd Ratio (95% CI)Odd Ratio (95% CI) AgeAge 0.080.08 0.940.94 (0.89 - 1.00)(0.89 - 1.00) SexSex 0.440.44 2.42.4 (0.26 - 21.84)(0.26 - 21.84) MI HistoryMI History 0.750.75 1.331.33 (0.22 - 0.89)(0.22 - 0.89) MI LocationMI Location 0.780.78 0.920.92 (0.53 - 1.61)(0.53 - 1.61) MI DurationMI Duration 0.210.21 0.990.99 (0.98 - 1.00)(0.98 - 1.00) DMDM 0.790.79 1.361.36 (0.14 - 13.20)(0.14 - 13.20) DLPDLP 0.770.77 0.810.81 (0.20 - 3.27)(0.20 - 3.27) HTNHTN 0.160.16 0.360.36 (0.08 - 1.50)(0.08 - 1.50) CigaretteCigarette SmokingSmoking 0.0340.034 0.160.16 (0.03 - 0.87)(0.03 - 0.87) FHFH 0.160.16 0.220.22 (0.03 - 1.82)(0.03 - 1.82) ResultsResults Cont,Cont,
  • 19. ConclusionsConclusions  UsingUsing conventional angioplasty wiresconventional angioplasty wires inin CTOCTO  High percentage of SuccessfulHigh percentage of Successful Percutaneous Coronary InterventionPercutaneous Coronary Intervention was achievedwas achieved  Low incidence of complicationsLow incidence of complications waswas seenseen  SmokingSmoking was a significant predictorwas a significant predictor of procedural failureof procedural failure
  • 20.  Smoking was a significant predictor of procedural failure